Naimi Johansson

Artiklar i tidskrifter

• Svensson, M. , Strand, G. C. , Bonander, C. , Johansson, N. & Jakobsson, N. (2024). Analyses of quality of life in cancer drug trials: a review of measurements and analytical choices in post-reimbursement studies. BMC Cancer, 24 (1).
• Johansson, N. , Jakobsson, N. & Svensson, M. (2024). Place or patient as the driver of regional variation in healthcare spending - Discrepancies by category of care. Social Science and Medicine, 342.
• Chauca Strand, G. , Johansson, N. , Jakobsson, N. , Bonander, C. & Svensson, M. (2023). Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?. Clinical drug investigation (43), 621-633.
• Fledsberg, S. , Svensson, M. & Johansson, N. (2023). Lifetime healthcare expenditures across socioeconomic groups in Sweden. European Journal of Public Health, 33 (6), 994-1000.
• Johansson, N. , de New, S. C. , Kunz, J. S. , Petrie, D. & Svensson, M. (2023). Reductions in out-of-pocket prices and forward-looking moral hazard in health care demand. Journal of Health Economics, 87.
• Chauca Strand, G. , Bonander, C. , Jakobsson, N. , Johansson, N. & Svensson, M. (2022). Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs. ESMO Open, 7 (5).
• Johansson, N. & Svensson, M. (2022). Regional variation in prescription drug spending: Evidence from regional migrants in Sweden. Health Economics, 31 (9), 1862-1877.
• Johansson, N. , Jakobsson, N. & Svensson, M. (2018). Regional variation in health care utilization in Sweden: the importance of demand-side factors. BMC Health Services Research, 18 (1).

Doktorsavhandlingar, sammanläggningar

• Johansson, N. (2021). Price sensitivity and regional variation in health care. (Doctoral dissertation). (Sammanläggning) Gothenburg: University of Gothenburg.

Manuskript

• de Brun, M. , Johansson, N. , Simmons, D. , Montgomery, S. , Berntorp, K. , Jansson, S. , Wennerholm, U. , Wikström, A. & et al. Healthcare cost consequences of changing diagnostic criteria for gestational diabetes mellitus (CDC4G) in Sweden : Alongside a stepped wedge cluster randomised trial.

Rapporter

• Johansson, N. (2021). Vad kan förklara regionala skillnader i svensk hälso­ och sjukvård?.. SNS förlag (SNS Analys 75).